cerebellum
| 3 min read
Unlike in other brain regions, levels of the neurotransmitter decrease in the cerebellum when anxiety is high, suggesting a potential new drug target.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
